Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Abroad (travel likely)Recruiting

Conditions

Malignant Bone Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Lu Xie, M.D.

    Principal Investigator

    Musculoskeletal Tumor Center of Peking University People's Hospital